Search

everythinglearnresearchcommunity

for

Search:↓

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

Cannabinoids may help some skin conditions but more research is needed.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.

People with chronic Hepatitis C often have skin problems like itching and contact dermatitis, especially older individuals and women.

Hair follicle stem cells can help treat ulcerative colitis in mice by releasing beneficial exosomes.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.